Kidney Disease: Improving Global Outcomes
Dr. Ian de Boer, professor (Nephrology) co-chaired the Kidney Disease: Improving Global Outcomes (KDIGO) 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Diseases (CKD).
The guideline is designed to apply to a broad population of patients with diabetes and CKD, while being mindful of implications for policy and payment. Type 1 and type 2 diabetes are both addressed, with differences in approach to management highlighted when appropriate.
“This update to the Diabetes Guideline again emphasizes patient-centeredness and a holistic approach to treatment for patients with diabetes and CKD,” said de Boer.
“Notably, the Work Group included two members with diabetes and CKD who contributed actively as peers to keep the guideline relevant and patient-centered. Incorporating patients as partners has become more common in research, and we are pleased to see that this model is being adopted by additional clinical practice guidelines.”